SmCo and NdFeB are the two workhorse rare-earth materials specified for implantable and patient-contacting magnetic assemblies, each selected on a different axis of the same trade-off curve [S1][S4].
SmCo is chosen for intrinsic corrosion resistance and thermal stability; NdFeB is chosen for maximum energy product per unit volume, and it always requires a biocompatible barrier coating for any body-contacting use [S1][S4].
Why biocompatibility gates magnet selection before field strength
Biocompatibility in a magnetic component means the magnet, its coating, and any residual surface chemistry must not trigger an immune response, corrode in body fluids, or leach harmful species over the device's implant life [S4].
ISO 10993 is the international benchmark series for biological evaluation of medical devices, and ISO 13485:2016 is the quality-management system certification expected of any magnet supplier producing into a medical device supply chain [S4][S5]. For US market access, FDA Blue Book Memoranda and the Quality System Regulation (21 CFR 820) layer on top, while EU MDR adds its own conformity-assessment burden [S2][S5]. Coatings alone are not enough: a magnet supplier without ISO 13485:2016 certification introduces compliance risk that no downstream coating audit can erase [S4].
SmCo vs NdFeB vs AlNiCo: criteria comparison
For body-contacting or implantable medical assemblies, the rare-earth pair (SmCo, NdFeB) dominates, and a magnet's magnetic properties matter as much as its corrosion response. The relevant criteria are intrinsic corrosion resistance, maximum operating temperature, energy product per unit volume, biocompatible coating requirement, and sterilization compatibility. [S4]
SmCo offers natural corrosion resistance and strong thermal stability, typically performing up to roughly 250 to 350 degrees Celsius depending on grade, which suits long-life implantable systems and autoclave-sterilized surgical tools [S1]. NdFeB delivers the highest energy product per unit volume in the rare-earth family, but the raw alloy is highly susceptible to corrosion in physiological media, so it requires parylene, titanium, gold, or hermetic encapsulation before any body contact [S1][S4]. AlNiCo is occasionally used in legacy sensor and actuator roles where temperature stability above 500 degrees Celsius matters more than compact strength, and it is generally used in external or non-implantable instrument housings where the magnet is sealed inside a stainless envelope.
A useful rule for spec writing: if the magnet sits inside a sealed titanium or stainless hermetic can, SmCo is usually unnecessary and NdFeB can be specified for size advantage; if the magnet contacts tissue directly or sits in a polymer-potted assembly that must survive autoclave or gamma sterilization, SmCo is the safer default [S1][S4].
Biocompatible coating options and what each one actually does
Parylene, titanium, and gold are the three most commonly specified biocompatible coatings for medical magnets, and each behaves differently under sterilization, flexure, and long-term body exposure [S1][S4].
Parylene C is a conformal polymer coating applied by chemical vapor deposition, typically 5 to 25 micrometers thick, valued for pinhole-free coverage of complex magnet geometries and USP Class VI biocompatibility; it is a good general-purpose barrier but has a finite flex life and is not a load-bearing surface [S1][S2][S4]. Titanium, applied by PVD or as a formed can, provides a hard, load-bearing, hermetic barrier and tolerates repeated autoclave cycles; it adds thickness and is typically reserved for implants where mechanical robustness matters more than miniaturization [S1][S2]. Gold over a nickel underlayer is specified where electrical conductivity, low oxide formation, or solderability is required, and it is common in cochlear and hearing-assist magnet stacks; gold is soft and can wear under sliding contact, so it is not chosen for articulating surfaces [S4].
Other materials that appear in biocompatible medical magnet assemblies include medical-grade silicone, polypropylene, alumina, hydroxyapatite, and bioglass, primarily as secondary encapsulation, pottings, or mating surfaces rather than direct magnet coatings [S2]. The engineering consequence: coating choice is a sterilizability decision as much as a chemistry decision. Steam autoclave, gamma irradiation, and ethylene oxide each degrade polymers differently, so a parylene-coated NdFeB magnet that survives EtO may crack or discolor under repeated autoclave cycles [S5].
Real use cases: cochlear, neurostim, drug delivery, VAD, surgical tools
Miniature NdFeB or SmCo magnets are embedded in cochlear implants for headset retention and in catheter-based systems for position sensing and tip alignment, where size and field precision dominate the spec [S4].
Neurostimulation systems (deep brain stimulators, spinal cord stimulators, vagus nerve stimulators) use SmCo or coated NdFeB magnet stacks in both the implantable pulse generator and the external controller, and stray-field control is critical to avoid interference with adjacent sensing electronics [S1][S3]. Drug-delivery capsules and ingestible systems use miniature rare-earth magnets for programmed closure, navigation under external field, and position reporting, which is where the high energy product of NdFeB enables sub-3 mm form factors that SmCo cannot match [S3][S4]. Ventricular assist devices and other blood-contacting pumps typically encapsulate the drive magnets inside a hermetic titanium can, so the magnet material inside is selected primarily on torque density and thermal margin; the biocompatibility burden is carried by the titanium envelope, not the magnet alloy [S2].
For minimally invasive surgical tools, magnets enable articulation, coupling, and position feedback; these are short-duration, external, or minimally invasive devices where ISO 10993 testing on the full assembly, including any coating, still applies but long-term implant-grade encapsulation is not required [S3][S4].
Failure modes engineers hit when magnet selection is wrong
Corrosion-driven particle generation is the dominant in-vivo failure mode for uncoated or under-coated NdFeB magnets, and even microscopic particles in cardio and neuro applications can trigger serious inflammatory complications [S1][S2].
Stray magnetic fields that are not characterized and controlled during design can interfere with adjacent electronics inside the same implantable device, from sensing front-ends to charging coils, and this is a common design-for-manufacture miss when engineering teams without magnetics experience set the spec [S2]. Sterilization-magnet incompatibility is the third recurring failure: a polymer coating that is qualified for EtO may not survive gamma, and gamma may embrittle certain encapsulants; this is why sterilization compatibility is treated as a material selection criterion on the same level as biocompatibility, not as a downstream test [S5]. Manufacturing tolerance creep, where micromachining of magnetized parts is done in a non-cleanroom environment, introduces both metallic and biological contamination that ISO 13485:2016 production controls are explicitly designed to prevent [S2][S4].
Regulatory and sourcing checklist before releasing the magnet BOM
The minimum compliance package for a medical magnet supplier is ISO 13485:2016 certification, ISO 10993 test data on the actual coated magnet assembly, and a sterilization-compatibility statement covering the specific cycle the device will see in production [S4][S5].
For US market access, the device manufacturer carries FDA Quality System Regulation (21 CFR 820) and Blue Book Memorandum obligations, including material characterization and process validation; for EU market access, MDR conformity assessment layers additional clinical-evaluation and post-market surveillance work on top of the material file [S2][S5]. Engineers should also confirm the supplier can hold a stable material grade across serial production, because magnetic variability inside an approved design file triggers a change-notification burden that is expensive to retrofit [S2].
The practical next step is to lock the magnet alloy (SmCo or NdFeB) and the coating system (Parylene C, titanium, or gold over nickel) in the design input document, then require the magnet vendor to ship ISO 10993 test reports, ISO 13485:2016 certificate, and sterilization validation data with first article. Related selection work for adjacent spec domains, including electronics and construction, is covered in magnetic material selection for electronics: a 2026 spec-first map and spec-first magnetic material selection for construction, 2026; the underlying material physics is summarized in the magnetic material encyclopedia entry.
The underlying component specifications are covered under magnetic sensor, and magnetic drive pump.